Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000891092-97-000265
Filing Date
1997-07-16
Accepted
1997-07-16 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT 424B3 1633
  Complete submission text file 0000891092-97-000265.txt   3106
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94025 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-13469 | Film No.: 97641208
SIC: 2836 Biological Products, (No Diagnostic Substances)